Your browser doesn't support javascript.
loading
Generation of CHOPi-008-B, a euploid iPSC line from a patient with Trisomy 21 and a GATA1 mutation.
Takasaki, Kaoru; Kumar, Sara S; Gagne, Alyssa; French, Deborah L; Chou, Stella T.
Afiliação
  • Takasaki K; Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: takasakik@chop.edu.
  • Kumar SS; Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Gagne A; Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • French DL; Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Chou ST; Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Stem Cell Res ; 72: 103198, 2023 10.
Article em En | MEDLINE | ID: mdl-37677872
ABSTRACT
Transient myeloproliferative disorder (TMD) is a pre-leukemic condition that occurs only in neonates with Trisomy 21 (T21), and is attributed to a genetic interaction between the third copy of chromosome 21 (HSA21) and a mutation in the transcription factor GATA1 that results in a truncated protein (GATA1s). We generated a euploid iPSC line with a GATA1s mutation that is isogenic to a previously published pair of T21 lines with and without a GATA1 mutation. The line was characterized for pluripotency, differentiation potential, and genomic stability. This line is a valuable isogenic control for studying the T21 hematopoietic phenotype.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Megacarioblástica Aguda / Síndrome de Down / Células-Tronco Pluripotentes Induzidas Limite: Humans / Newborn Idioma: En Revista: Stem Cell Res Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Megacarioblástica Aguda / Síndrome de Down / Células-Tronco Pluripotentes Induzidas Limite: Humans / Newborn Idioma: En Revista: Stem Cell Res Ano de publicação: 2023 Tipo de documento: Article